Silymarin is a flavonolignans extracted from the milk thistle Silybum marianum (L.) gaernt. Silymarin has been shown to possess various pharmacological properties like hepatoprotective, antioxidant, antiinflammatory, anticancer, and cardioprotective activities.
The global market for Silymarin was estimated to be worth US$ 90 million in 2023 and is forecast to a readjusted size of US$ 112.5 million by 2030 with a CAGR of 3.2% during the forecast period 2024-2030
The top players cover LIVERD PHARMA, TY Pharmaceutical, KEB Biotech, etc. The Top 3 players in Global Silymarin market revenue was 50.46% in 2019, while the share of top 5 players was 61.99%. TY Pharmaceutical is the leading supplier of Silymarin, the production of which reached 438 MT in 2019, accounting for about 18.81% of the Global market. Market concentration is high. Except policy affect, downstream demand is the key influence factor to the market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Silymarin, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Silymarin by region & country, by Type, and by Application.
The Silymarin market size, estimations, and forecasts are provided in terms of sales volume (MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Silymarin.
Market Segmentation
By Company
LIVERD PHARMA
Huacheng Pharmaceutical
TY Pharmaceutical
Teva API
KEB Biotech
Shengbo Silymarin
Panjin Fengrui
Jiaherb
Segment by Type:
Silymarin Extracted by Acetone
Silymarin Extracted by Ethyl Acetate
Silymarin Extracted by Ethanol
Water Soluble Silymarin
Segment by Application
Pharma and Healthcare
Food Additives
Cosmetic and Skin Care
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Silymarin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Silymarin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Silymarin in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Silymarin Product Introduction
1.2 Global Silymarin Market Size Forecast
1.2.1 Global Silymarin Sales Value (2019-2030)
1.2.2 Global Silymarin Sales Volume (2019-2030)
1.2.3 Global Silymarin Sales Price (2019-2030)
1.3 Silymarin Market Trends & Drivers
1.3.1 Silymarin Industry Trends
1.3.2 Silymarin Market Drivers & Opportunity
1.3.3 Silymarin Market Challenges
1.3.4 Silymarin Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Silymarin Players Revenue Ranking (2023)
2.2 Global Silymarin Revenue by Company (2019-2024)
2.3 Global Silymarin Players Sales Volume Ranking (2023)
2.4 Global Silymarin Sales Volume by Company Players (2019-2024)
2.5 Global Silymarin Average Price by Company (2019-2024)
2.6 Key Manufacturers Silymarin Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Silymarin Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Silymarin
2.9 Silymarin Market Competitive Analysis
2.9.1 Silymarin Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Silymarin Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Silymarin as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Silymarin Extracted by Acetone
3.1.2 Silymarin Extracted by Ethyl Acetate
3.1.3 Silymarin Extracted by Ethanol
3.1.4 Water Soluble Silymarin
3.2 Global Silymarin Sales Value by Type
3.2.1 Global Silymarin Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Silymarin Sales Value, by Type (2019-2030)
3.2.3 Global Silymarin Sales Value, by Type (%) (2019-2030)
3.3 Global Silymarin Sales Volume by Type
3.3.1 Global Silymarin Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Silymarin Sales Volume, by Type (2019-2030)
3.3.3 Global Silymarin Sales Volume, by Type (%) (2019-2030)
3.4 Global Silymarin Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharma and Healthcare
4.1.2 Food Additives
4.1.3 Cosmetic and Skin Care
4.1.4 Others
4.2 Global Silymarin Sales Value by Application
4.2.1 Global Silymarin Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Silymarin Sales Value, by Application (2019-2030)
4.2.3 Global Silymarin Sales Value, by Application (%) (2019-2030)
4.3 Global Silymarin Sales Volume by Application
4.3.1 Global Silymarin Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Silymarin Sales Volume, by Application (2019-2030)
4.3.3 Global Silymarin Sales Volume, by Application (%) (2019-2030)
4.4 Global Silymarin Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Silymarin Sales Value by Region
5.1.1 Global Silymarin Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Silymarin Sales Value by Region (2019-2024)
5.1.3 Global Silymarin Sales Value by Region (2025-2030)
5.1.4 Global Silymarin Sales Value by Region (%), (2019-2030)
5.2 Global Silymarin Sales Volume by Region
5.2.1 Global Silymarin Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Silymarin Sales Volume by Region (2019-2024)
5.2.3 Global Silymarin Sales Volume by Region (2025-2030)
5.2.4 Global Silymarin Sales Volume by Region (%), (2019-2030)
5.3 Global Silymarin Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Silymarin Sales Value, 2019-2030
5.4.2 North America Silymarin Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Silymarin Sales Value, 2019-2030
5.5.2 Europe Silymarin Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Silymarin Sales Value, 2019-2030
5.6.2 Asia Pacific Silymarin Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Silymarin Sales Value, 2019-2030
5.7.2 South America Silymarin Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Silymarin Sales Value, 2019-2030
5.8.2 Middle East & Africa Silymarin Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Silymarin Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Silymarin Sales Value
6.2.1 Key Countries/Regions Silymarin Sales Value, 2019-2030
6.2.2 Key Countries/Regions Silymarin Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Silymarin Sales Value, 2019-2030
6.3.2 United States Silymarin Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Silymarin Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Silymarin Sales Value, 2019-2030
6.4.2 Europe Silymarin Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Silymarin Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Silymarin Sales Value, 2019-2030
6.5.2 China Silymarin Sales Value by Type (%), 2023 VS 2030
6.5.3 China Silymarin Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Silymarin Sales Value, 2019-2030
6.6.2 Japan Silymarin Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Silymarin Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Silymarin Sales Value, 2019-2030
6.7.2 South Korea Silymarin Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Silymarin Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Silymarin Sales Value, 2019-2030
6.8.2 Southeast Asia Silymarin Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Silymarin Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Silymarin Sales Value, 2019-2030
6.9.2 India Silymarin Sales Value by Type (%), 2023 VS 2030
6.9.3 India Silymarin Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 LIVERD PHARMA
7.1.1 LIVERD PHARMA Company Information
7.1.2 LIVERD PHARMA Introduction and Business Overview
7.1.3 LIVERD PHARMA Silymarin Sales, Revenue and Gross Margin (2019-2024)
7.1.4 LIVERD PHARMA Silymarin Product Offerings
7.1.5 LIVERD PHARMA Recent Development
7.2 Huacheng Pharmaceutical
7.2.1 Huacheng Pharmaceutical Company Information
7.2.2 Huacheng Pharmaceutical Introduction and Business Overview
7.2.3 Huacheng Pharmaceutical Silymarin Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Huacheng Pharmaceutical Silymarin Product Offerings
7.2.5 Huacheng Pharmaceutical Recent Development
7.3 TY Pharmaceutical
7.3.1 TY Pharmaceutical Company Information
7.3.2 TY Pharmaceutical Introduction and Business Overview
7.3.3 TY Pharmaceutical Silymarin Sales, Revenue and Gross Margin (2019-2024)
7.3.4 TY Pharmaceutical Silymarin Product Offerings
7.3.5 TY Pharmaceutical Recent Development
7.4 Teva API
7.4.1 Teva API Company Information
7.4.2 Teva API Introduction and Business Overview
7.4.3 Teva API Silymarin Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Teva API Silymarin Product Offerings
7.4.5 Teva API Recent Development
7.5 KEB Biotech
7.5.1 KEB Biotech Company Information
7.5.2 KEB Biotech Introduction and Business Overview
7.5.3 KEB Biotech Silymarin Sales, Revenue and Gross Margin (2019-2024)
7.5.4 KEB Biotech Silymarin Product Offerings
7.5.5 KEB Biotech Recent Development
7.6 Shengbo Silymarin
7.6.1 Shengbo Silymarin Company Information
7.6.2 Shengbo Silymarin Introduction and Business Overview
7.6.3 Shengbo Silymarin Silymarin Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Shengbo Silymarin Silymarin Product Offerings
7.6.5 Shengbo Silymarin Recent Development
7.7 Panjin Fengrui
7.7.1 Panjin Fengrui Company Information
7.7.2 Panjin Fengrui Introduction and Business Overview
7.7.3 Panjin Fengrui Silymarin Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Panjin Fengrui Silymarin Product Offerings
7.7.5 Panjin Fengrui Recent Development
7.8 Jiaherb
7.8.1 Jiaherb Company Information
7.8.2 Jiaherb Introduction and Business Overview
7.8.3 Jiaherb Silymarin Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Jiaherb Silymarin Product Offerings
7.8.5 Jiaherb Recent Development
8 Industry Chain Analysis
8.1 Silymarin Industrial Chain
8.2 Silymarin Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Silymarin Sales Model
8.5.2 Sales Channel
8.5.3 Silymarin Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
LIVERD PHARMA
Huacheng Pharmaceutical
TY Pharmaceutical
Teva API
KEB Biotech
Shengbo Silymarin
Panjin Fengrui
Jiaherb
*If Applicable.